...
首页> 外文期刊>Transplantation: Official Journal of the Transplantation Society >Cold ischemia does not interfere with tolerance induction.
【24h】

Cold ischemia does not interfere with tolerance induction.

机译:冷缺血不会干扰耐受性诱导。

获取原文
获取原文并翻译 | 示例

摘要

BACKGROUND: Ischemia/reperfusion injury activates innate immunity, which in turn may prevent tolerance induction. We asked whether prolonged cold ischemia interferes with successful tolerance induction. METHODS: Kidneys from Dark Agouti donors were grafted into binephrectomized Lewis rats after short (20 min) or prolonged (6 hr) cold ischemia. Tolerance was induced by nondepleting anti-CD4 monoclonal antibody RIB 5/2 (10 mg/kg for 5 days). Binephrectomized untreated and cytotoxic T-lymphocyte antigen (CTLA)-4Ig treated recipients served as controls. Animals were followed for 100 days. Adoptive transfer experiments into sublethally irradiated naive Lewis were performed at day 100. Animals received kidneys from Dark Agouti rats subsequently without further immunosuppression and were followed for an additional 20 days. RESULTS: All RIB 5/2-treated recipients survived the first observation period independent of the cold ischemia time. Graft function, morphology, and transferred T-cell numbers were comparable in both groups. Twenty days after transfer amounts of intragraft and peripheral donor-derived cells were significantly reduced in recipients of the initially prolonged cold ischemia group associated with an attenuated immune response. CONCLUSIONS: Our results prove that an initially extended cold ischemia does not interfere with tolerance induced by RIB 5/2. Moreover, we conclude that a tolerizing conditioning tolerance-induction phase may reduce the immune response in recipients of an adoptive cell transfer.
机译:背景:缺血/再灌注损伤会激活先天免疫,进而可能阻止耐受耐受性。我们询问长时间的冷缺血是否会干扰成功的耐受性诱导。方法:在短暂(20分钟)或长时间(6小时)的冷缺血后,将来自黑暗Agouti供体的肾脏移植到经双肾切除的Lewis大鼠中。通过不消耗抗CD4单克隆抗体RIB 5/2(10 mg / kg,持续5天)诱导耐受。经双肾切除的未治疗和细胞毒性T淋巴细胞抗原(CTLA)-4Ig治疗的受体作为对照。跟踪动物100天。在第100天进行过亚致死剂量辐照的幼稚Lewis的过继转移实验。动物随后从Dark Agouti大鼠接受肾脏,而没有进一步的免疫抑制,并再随访20天。结果:所有接受RIB 5/2治疗的接受者均在第一个观察期中存活,与冷缺血时间无关。两组的移植物功能,形态和转移的T细胞数量相当。转移后二十天,与免疫应答减弱有关的最初延长的冷缺血组的受体中,移植物和外周供体来源的细胞数量明显减少。结论:我们的结果证明,最初扩展的冷缺血不会干扰RIB 5/2诱导的耐受性。此外,我们得出结论,耐受条件耐受诱导阶段可能会降低过继细胞转移受体的免疫反应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号